171.30
price down icon3.83%   -6.83
after-market 시간 외 거래: 171.30
loading
전일 마감가:
$178.13
열려 있는:
$170.91
하루 거래량:
444.67K
Relative Volume:
1.68
시가총액:
$5.00B
수익:
$290.51M
순이익/손실:
$89.16M
주가수익비율:
57.29
EPS:
2.99
순현금흐름:
$119.18M
1주 성능:
-6.86%
1개월 성능:
-2.24%
6개월 성능:
-3.28%
1년 성능:
-4.02%
1일 변동 폭
Value
$166.89
$173.99
1주일 범위
Value
$166.89
$182.16
52주 변동 폭
Value
$141.72
$219.34

Krystal Biotech Inc Stock (KRYS) Company Profile

Name
명칭
Krystal Biotech Inc
Name
전화
(412) 586-5830
Name
주소
2100 WHARTON STREET, PITTSBURGH, PA
Name
직원
275
Name
트위터
@KrystalBiotech
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
KRYS's Discussions on Twitter

KRYS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KRYS
Krystal Biotech Inc
171.30 5.00B 290.51M 89.16M 119.18M 2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-05 개시 Jefferies Buy
2024-08-06 다운그레이드 Citigroup Buy → Neutral
2023-11-20 개시 Goldman Buy
2023-10-24 개시 Cantor Fitzgerald Overweight
2023-10-12 개시 Citigroup Buy
2023-09-07 개시 Berenberg Buy
2023-04-18 개시 Stifel Buy
2023-02-28 업그레이드 Goldman Neutral → Buy
2022-08-25 다운그레이드 Goldman Buy → Neutral
2022-01-18 개시 BofA Securities Buy
2021-07-20 업그레이드 Goldman Neutral → Buy
2020-09-18 개시 B. Riley FBR Buy
2020-06-04 개시 Evercore ISI Outperform
2019-09-24 개시 Goldman Neutral
2019-08-06 재확인 H.C. Wainwright Buy
2019-06-24 재확인 Chardan Capital Markets Buy
2019-06-24 재확인 H.C. Wainwright Buy
2019-05-30 개시 Guggenheim Buy
2018-09-11 개시 Cantor Fitzgerald Overweight
모두보기

Krystal Biotech Inc 주식(KRYS)의 최신 뉴스

pulisher
05:27 AM

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Sei Investments Co. - Defense World

05:27 AM
pulisher
Apr 03, 2025

Commonwealth Equity Services LLC Boosts Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

(KRYS) Proactive Strategies - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Mar 30, 2025

Teacher Retirement System of Texas Purchases 1,369 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Teacher Retirement System of Texas - Defense World

Mar 30, 2025
pulisher
Mar 25, 2025

US High Growth Tech Stocks With Promising Potential - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEK - Seeking Alpha

Mar 24, 2025
pulisher
Mar 21, 2025

How To Trade (KRYS) - news.stocktradersdaily.com

Mar 21, 2025
pulisher
Mar 21, 2025

3 High Growth Companies Insiders Are Betting On - simplywall.st

Mar 21, 2025
pulisher
Mar 21, 2025

Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue? - Yahoo

Mar 21, 2025
pulisher
Mar 20, 2025

Analysts Set Krystal Biotech, Inc. (NASDAQ:KRYS) PT at $220.00 - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Raymond James Financial Inc. Takes $15.99 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Is Krystal Biotech, Inc.'s (NASDAQ:KRYS) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Simply Wall St

Mar 18, 2025
pulisher
Mar 17, 2025

Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

US Bancorp DE Grows Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Position Increased by Charles Schwab Investment Management Inc. - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Krystal Biotech president Suma Krishnan sells $8.9 million in shares By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 13, 2025

Krystal Biotech CEO Krishnan sells $8.89 million in stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Krystal Biotech president Suma Krishnan sells $8.9 million in shares - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Krystal Biotech CEO Krishnan sells $8.89 million in stock - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Keybank National Association OH - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

How to Take Advantage of moves in (KRYS) - news.stocktradersdaily.com

Mar 11, 2025
pulisher
Mar 10, 2025

Bank of New York Mellon Corp Has $26.53 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait? - Nasdaq

Mar 08, 2025
pulisher
Mar 08, 2025

Krystal Biotech (NASDAQ:KRYS) Earns Buy Rating from Analysts at Jefferies Financial Group - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Krystal Biotech initiated at buy at Jefferies on Vyjuvek, gene delivery tech - MSN

Mar 07, 2025
pulisher
Mar 06, 2025

Krystal Biotech at TD Cowen Conference: Strategic Pipeline Progress By Investing.com - Investing.com Canada

Mar 06, 2025
pulisher
Mar 05, 2025

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 05, 2025
pulisher
Mar 05, 2025

Krystal Biotech’s Growth Potential: Strong Vyjuvek Launch and Promising Pipeline - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Jefferies Initiates Krystal Biotech at Buy With $245 Price Target -March 05, 2025 at 07:22 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Jefferies Initiates Coverage of Krystal Biotech (KRYS) with Buy Recommendation - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Jefferies sets Krystal Biotech stock Buy rating, $245 target By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Krystal Biotech initiated with a Buy at Jefferies - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Gene Therapy Market Top Companies Study-Krystal Biotech, Inc., - openPR

Mar 05, 2025
pulisher
Mar 03, 2025

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga

Mar 03, 2025
pulisher
Mar 03, 2025

Is the Market Bullish or Bearish on Krystal Biotech? - Benzinga

Mar 03, 2025
pulisher
Mar 03, 2025

KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

H.C. Wainwright maintains $221 target on Krystal Biotech stock By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

H.C. Wainwright maintains $221 target on Krystal Biotech stock - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Krystal Biotech’s (KRYS) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

New York State Common Retirement Fund Has $3.66 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Principal Financial Group Inc. Purchases 3,727 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Krystal gets positive EU regulatory opinion for Vyjuvek - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Krystal Biotech chief accounting officer sells $131,415 in stock - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

Krystal Biotech chief accounting officer sells $131,415 in stock By Investing.com - Investing.com UK

Feb 28, 2025
pulisher
Feb 28, 2025

Solid Earnings Reflect Krystal Biotech's (NASDAQ:KRYS) Strength As A Business - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

(KRYS) On The My Stocks Page - Stock Traders Daily

Feb 28, 2025
pulisher
Feb 28, 2025

Krystal gets positive EU regulatory opinion for Vyjuvek (KRYS:NASDAQ) - Seeking Alpha

Feb 28, 2025
pulisher
Feb 28, 2025

Krystal Biotech’s Vyjuvek: Anticipated European Approval and Strong Sales Projections Drive Buy Rating - TipRanks

Feb 28, 2025

Krystal Biotech Inc (KRYS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):